Active: ESC Heart Fail Clear all

GWAS 2022-06-23

Pharmacogenomic study of heart failure and candesartan response from the CHARM programme.

Dubé MP, Chazara O et al.

ESC Heart Fail

Aims: The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) pr...

Cardiovascular death or hospitalisation in heart failure

2727

Participants

N/A

Studies

Details PubMed

GWAS 2021-11-03

Impact of natriuretic peptide polymorphisms on diastolic and metabolic function in a populational cohort: insights from the STANISLAS cohort.

Xhaard C, Rouget R et al.

ESC Heart Fail

Aims: Elevated brain natriuretic peptide (BNP) and the N-terminal fragment of its pro-hormone (NT-pr...

N-terminal prohormone brain natriuretic peptide levels

1555

Participants

N/A

Studies

Details PubMed

GWAS 2020-09-01

A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy.

de Denus S, Mottet F et al.

ESC Heart Fail

Aims: Few investigations have been conducted to identify genetic determinants of common, polygenetic...

Heart failure

2328

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

Pharmacogenomic study of heart failure and candesartan response from the CHARM programme.

Dubé MP, Chazara O et al.

ESC Heart Fail

Cardiovascular death or hospitalisation in heart failure

2022-06-23

Impact of natriuretic peptide polymorphisms on diastolic and metabolic function in a populational cohort: insights from the STANISLAS cohort.

Xhaard C, Rouget R et al.

ESC Heart Fail

N-terminal prohormone brain natriuretic peptide levels

2021-11-03

A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy.

de Denus S, Mottet F et al.

ESC Heart Fail

Heart failure

2020-09-01